Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Immunologic Deficiency Syndromes 3Hematologic Neoplasms 3Thalassemia 2Myelodysplastic Syndromes 2Hemoglobinopathies 2Fanconi Anemia 2Anemia, Sickle Cell 2Multiple Myeloma 1Metabolic Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Anemia, Aplastic 1

Interventions

fludarabine 2Surveys and Questionnaires 2fludarabine phosphate 1Thiotepa 1Registries 1Range of Motion, Articular 1Protease Inhibitors 1Melphalan 1Interviews as Topic 1Erythrocyte Count 1Clofarabine 1Bone Marrow Transplantation 1Blood Transfusion 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Anemia, Sickle Cell × fludarabine × Clear all
NCT01316549 2021-10-04

HCT

University of California, San Francisco

Completed
67 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT03609814 2021-10-04

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

University of California, San Francisco

Completed
30 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡